Novartis touts 5-year Cosentyx data as it works to hold top spot in psoriasis
admin 13th September 2017 Uncategorised 0Looking to stand out in an increasingly crowded field of newcomers, Novartis is publishing 5-year data for Cosentyx showing long-term skin clearance in psoriasis patients. The data come as Novartis contends in the next-gen psoriasis space with Eli Lilly, Valeant and now Johnson & Johnson.
More: Novartis touts 5-year Cosentyx data as it works to hold top spot in psoriasis
Source: fierce